Navigation Links
Synthes and Lilly Sign Development and Collaboration Agreement
Date:6/9/2011

onal strengths of each partner," said Michel Orsinger, president and CEO of Synthes. "Osteoporosis is one of the most significant unsolved clinical problems in orthopedics. Addressing the osteoporosis disease as well as the resulting fracture and bone defect is a significant strategic priority of both organizations," he continued. "Strategic collaborations between medtech and pharma companies represent a new and promising avenue to develop and market true innovations in a changing, dynamic market environment."

"We believe that patients worldwide will benefit from this collaboration because together we will be able to look for new ways to treat osteoporosis and bone fractures," said Bryce Carmine, executive vice president and president, Lilly Bio-Medicines, Eli Lilly and Company. "At Lilly, we are always exploring new opportunities to bring innovative medicines to people with unmet medical needs and improve outcomes for individual patients."

"Many orthopedic surgeons are in the position to diagnose and treat osteoporosis when their patients present with fractures, and we believe it is imperative to treat the underlying cause of the initial fracture," said Johnston Erwin, Bone/Muscle/Joint global development platform leader, Lilly Bio-Medicines, Eli Lilly and Company. "Our collaboration will also explore ways to treat fractures with Forteo in older patients and/or those who have osteoporosis and, longer term, will look for new ways to deliver medicine locally to the fracture site."

Financial terms of the agreement have not been disclosed.

Forteo, an FDA-approved osteoporosis therapy to help build new bone, is a treatment for postmenopausal women with osteoporosis who are at high risk for fracture(1) and to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.(2) Individuals at high risk for having broken bones include men and women with either a history of broken bones due to osteoporosis, who
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
2. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
3. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
7. Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas
8. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
9. Lilly Comments on Court Ruling in Amylin Litigation
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... Society of Clinical Oncology    PharmaMar comunica ... SAR3007, resi noti dal dipartimento Ricerca e sviluppo ... miglioramento della sopravvivenza libera da progressione (PFS) dopo il ... con dacarbazina in pazienti con liposarcoma (LPS) o leiomiosarcoma ...
(Date:6/1/2015)... June 2, 2015 Amgen (NASDAQ: ... on a Phase 1b study to evaluate the ... oncolytic immunotherapy, in combination with Roche,s investigational anti-PDL1 ... with triple-negative breast cancer and colorectal cancer with ... investigational oncolytic immunotherapy designed to selectively replicate in ...
(Date:6/1/2015)... 1, 2015 Research ... the addition of the "Analysis of ... report to their offering.      ... in-depth analysis of the US Medical Image ... market dynamics, and trends across the US ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Analysis of the US Medical Image Displays Market 2015-2017 2
(Date:6/2/2015)... 2015 Thermi, formerly ThermiAesthetics, a ... successfully transitioned into its new company headquarters in ... company’s continued rapid worldwide expansion and houses the ... 25 Thermi employees, including those of the warehousing, ... “As one of the fastest growing aesthetic companies ...
(Date:6/2/2015)... June 02, 2015 Atlantic Spine ... spine surgery with three locations in New Jersey, announces ... City. The new facility is at 1045 Park Avenue ... consultations and appointments can be arranged by calling 1-844-912-2406. ... at Atlantic Spine Center, has been a pioneer in ...
(Date:6/2/2015)... Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... publisher of audit, compliance and risk solutions ... a new online risk management effectiveness gap-improvement program. ... the effect of uncertainty on objectives. Organizations not ... they improve their capabilities to do this (risk ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in life coaching. NAPW is ... boasting more than 700,000 members and over 200 operating ... with this distinction,” said NAPW President Star Jones. “Her ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Everette-Gaines as a 2015-2016 inductee into its VIP ... with this prestigious distinction for leadership in business. ... for professional women, boasting more than 700,000 members ... pleased to welcome Kathy into this exceptional group ...
Breaking Medicine News(10 mins):Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2
... MIAMI, May 23 MDWebLive.com, offering live video,medical consultations ... has been launched in Miami by AmeriGroup,Holdings, Inc., ... their,doctors from home, office, hotel or anywhere else in ... for use with non-urgent healthcare related matters such as ...
... Amy Philo*, SAN DIEGO, May 23 ... May 10, 1998, Sharon Alley stabbed her eight,month ... Months before, Alley,was prescribed Paxil, became psychotic, and ... skull., Postpartum Support International (PSI) founder Jane ...
... and Health Care ... Service Offerings, BETHESDA, ... of Atlanta, Georgia based Eagle Group,International, LLC. Eagle Group provides logistics, ... Founded in 1995, Eagle Group employs more than 1,350 people. ...
... at Panther Expedited Services, Inc. selects the ... Prevent Cancer Foundation as Beneficiary, ALEXANDRIA, Va., ... chosen by Panther Expedited Services, Inc. as a,recipient of their ... Panther, a leader in premium air and ground transportation,headquartered in ...
... Anti-reflux procedure improved quality of life, cut need ... News) -- High levels of patient satisfaction and ... with gastroesophageal reflux disease (GERD) who had minimally ... experienced surgeon, says a U.S. study. , ...
... 21, 2008 A recent study shows that pre-operative assessments ... for early diagnosis and successful treatment of lymphedema. , ... (NNMC) and the National Institutes of Health (NIH) and ... Mason University, was published in the journal, Cancer (April ...
Cached Medicine News:Health News:Real Time, Face-to-Face Doctor Visits Now Available Online 2Health News:The MOTHERS Act: Thalidomide Revisited? 2Health News:The MOTHERS Act: Thalidomide Revisited? 3Health News:The MOTHERS Act: Thalidomide Revisited? 4Health News:Lockheed Martin Completes Acquisition of Eagle Group International, LLC 2Health News:New Supporters Join the Prevent Cancer Foundation Mission 2Health News:Patients Pleased With Laparoscopic GERD Surgery 2Health News:New study shows positive role physical therapists play in lymphedema diagnois and treatment 2
... Lobob hard contact lens cleaning ... to use, and professionally proven ... non-ionic detergents resulting in a ... protein deposits, cosmetic residue, salts, ...
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
Round knurled handle. Overall length 130 mm....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: